Wednesday, November 24, 2021

Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke

WHOM  is responsible for solving this? No specific person, nothing will get done.

Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke

Fiehler, Jens; Nawka, Marie Teresa; Meyer, Lukas

Author Information
Current Opinion in Neurology: November 22, 2021 - Volume - Issue -
doi: 10.1097/WCO.0000000000001006
  • Buy
  • PAP

Abstract

Purpose of review 

Although endovascular treatment (EVT) is the gold standard for treating acute stroke patients with large vessel occlusion (LVO), multiple challenges in decision-making for specific conditions persist. Recent evidence on a selection of patient subgroups will be discussed in this narrative review.

Recent findings 

Two randomized controlled trials (RCTs) have been published in EVT of basilar artery occlusion (BAO). Large single arm studies showed promising results in Patients with low Alberta stroke program early CT score (ASPECTS) and more distal vessel occlusions. Recent data confirm patients with low National Institutes of Health Stroke Scale (NIHSS) despite LVO to represent a heterogeneous and challenging patient group.

Summary 

The current evidence does not justify withholding EVT from BAO patients as none of the RCTs showed any signal of superiority of BMT alone vs. EVT. Patients with low ASPECTS, more distal vessel occlusions and patients with low NIHSS scores should be included into RCTs if possible. Without participation in a RCT, patients should be selected for EVT based on age, severity and type of neurological impairment, time since symptom onset, location of the ischaemic lesion and perhaps also results of advanced imaging.

 
 

No comments:

Post a Comment